Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LVTX | AZN | AMGN | GILD | VRTX |
| Company | Lava Therapeutics N.V. | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.8100 | 90.45 | 344.14 | 129.13 | 463.74 |
| High | 1.8200 | 91.79 | 349.98 | 133.10 | 472.58 |
| Low | 1.6200 | 90.17 | 342.14 | 129.00 | 458.31 |
| Latest | 1.7400 | 91.69 | 347.07 | 131.14 | 467.35 |
| Change | -0.0700 | +1.15 | +3.47 | +2.03 | +6.21 |
| % Change | -3.87% | +1.27% | +1.01% | +1.57% | +1.35% |
| Volume | 285,500 | 6,145,200 | 3,025,100 | 8,550,500 | 1,535,000 |
| 20-Day Average Volume | 131,750 | 8,190,060 | 2,328,485 | 5,808,140 | 1,286,930 |
| Previous Close | 1.8100 | 90.54 | 343.60 | 129.11 | 461.14 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6475 | 93.05 | 331.07 | 123.64 | 457.73 |
| 20-Day Raw Stochastic | 65.31% | 35.48% | 90.84% | 87.92% | 65.53% |
| 20-Day Relative Strength | 61.37 | 50.43 | 62.19 | 61.17 | 57.19 |
| Weighted Alpha | +38.19 | +34.67 | +29.23 | +39.58 | +9.58 |
| Today's Opinion | 100% Buy | 80% Buy | 88% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 64% Buy | 88% Buy | 96% Buy | 72% Buy |
| Last Month's Opinion | 96% Buy | 100% Buy | 72% Buy | 88% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.35% since 11/13/25 | -4.83% since 01/14/26 | +5.50% since 01/14/26 | +5.70% since 01/14/26 | +3.96% since 01/14/26 |
| Low | 1.6000 on 11/17/25 | 89.04 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 429.00 on 01/20/26 |
| High | 1.8250 on 11/18/25 | 95.36 on 01/15/26 | 349.98 on 01/22/26 | 133.10 on 01/22/26 | 472.58 on 01/22/26 |
| 1-Month | |||||
| %Chg | +16.78% since 10/20/25 | +0.15% since 12/22/25 | +4.73% since 12/22/25 | +5.62% since 12/22/25 | +1.53% since 12/22/25 |
| Low | 1.4500 on 10/22/25 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 1.8250 on 11/18/25 | 96.51 on 01/07/26 | 349.98 on 01/22/26 | 133.10 on 01/22/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +14.10% since 08/20/25 | +9.90% since 10/22/25 | +17.26% since 10/22/25 | +7.97% since 10/22/25 | +9.59% since 10/22/25 |
| Low | 1.4000 on 09/19/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 1.8250 on 11/18/25 | 96.51 on 01/07/26 | 349.98 on 01/22/26 | 133.10 on 01/22/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +31.82% since 05/20/25 | +30.09% since 07/22/25 | +13.54% since 07/22/25 | +19.03% since 07/22/25 | -0.59% since 07/22/25 |
| Low | 1.1800 on 05/30/25 | 71.49 on 07/28/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 1.8250 on 11/18/25 | 96.51 on 01/07/26 | 349.98 on 01/22/26 | 133.10 on 01/22/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 45,771 | 280,838,432 | 185,022,080 | 160,184,192 | 116,999,984 |
| Shares Outstanding, K | 26,305 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 11,980,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -25,110,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -7,190,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.50 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 11/06/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/27/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.68 | 15.13 | 15.16 | 28.88 |